Florent Guerville

Dr. Florent Guerville


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
FGFlorent Guerville
Florent Guerville
IBIsabelle Bourdel-Marchasson
Isabelle Bourdel-Marchasson
JDJulie Déchanet-Merville
Julie Déchanet-Merville
IPIsabelle Pellegrin
Isabelle Pellegrin
Pierre Louis SoubeyranPierre Louis Soubeyran
Pierre Louis Soubeyran
MLMaël Lemoine
Maël Lemoine
Aging is associated with chronic low-grade inflammation, cancer incidence and mortality. As inflammation contributes to cancer initiation and progression, one could hypothesize that age-associated chronic low-grade inflammation contributes to the increase in cancer incidence and/or mortality observed during aging. Here, we review the evidence supporting this hypothesis: (1) epidemiological associations between biomarkers of systemic inflammation and cancer incidence and mortality in older people, (2) therapeutic clues suggesting that targeting inflammation could reduce cancer incidence and mortality and (3) experimental evidence from animal models highlighting inflammation as a link between various mechanisms of aging and cancer initiation and progression. Despite a large body of literature linking aging, inflammation and cancer, convincing evidence for the clear implication of specific inflammatory pathways explaining cancer incidence or mortality during aging is still lacking. Further dedicated research is needed to fill these gaps in evidence and pave the way for the development of applications in clinical care.